Licensing Out
Partnered Molecules
- Vitamin D3
- Paracetamol
- Clodronate
- Glibenclamide + Metformin
- Paracetamol + Codein
- RRR-α-Tocopherol
- Neridronate
Partnerships
- Kent Pharmaceuticals - Ashford (UK)
- Bioavenir - Herzelia Pituach (IL)
- Chiesi Farmaceutici - Parma (IT)
- Galen - Craigavon (UK)
- Gebro Pharma – Liestal (CH)
- Grunenthal GmbH - Aachen (DE)
- IBN Savio - Ronco Scrivia/Genova (IT)
- Italfarmaco – Cinisello Balsamo/Milano (IT)
- Mediport - Seoul (KR)
- Newbridge Pharmaceuticals - Dubai (UAE)
- Omikron - Roma (IT)
- Pharmacenter – Budapest (HU)
- SPA - Milano (IT)
- Sunovion Pharmaceuticals Inc. - Ontario (CA)
- Phoenix Middle East LTD (Egypt)
- Innovapharm LLC (Armenia)
- Incomed sh.p.k (Albania)
- Al Omawi Drugstore (Jordan)
- Pharmalink (UAE)
- Amicus Sa (CH)
- Laboratorios Effik S.A.U. (Spain)
- A. Menarini Latin America S.L.U.
Territories
- Italy
- Switzerland
- United Kingdom
- Ireland
- Spain
- Greece
- Cyprus
- Portugal
- Belgium
- USA
- Canada
- Iraq
- Kuwait
- Israel
- Lebanon
- South Korea
- Saudi Arabia
- United Arab Emirates
- Egypt
- Armenia
- Albania
- Jordan
- Serbia
- Montenegro
- Macedonia
- Kosovo
- Bosnia
- Croatia
- Slovenia
- Latvia
- Lithuania
- Estonia
- Bulgaria
- Hungary
- Guatemala
- El Salvador
- Honduras
- Nicaragua
- Costa Rica
- Panama
- Dominican Republic
- Belize